Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups
about
Viral hepatitis and hepatocellular carcinomaChronic HCV infection: epidemiological and clinical relevanceHepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impactAlcoholic liver disease and hepatitis C: a frequently underestimated combinationPharmacological treatments for chronic hepatitis C liver disease: a network meta-analysisPharmacological treatments for acute hepatitis C infection: a network meta-analysisRibavirin monotherapy for chronic hepatitis CRibavirin plus interferon versus interferon for chronic hepatitis CBile acids for viral hepatitisPegylated interferon for acute hepatitis CColchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosisClinical Profiles of Chronic Hepatitis C in a Major County Medical Center Outpatient Setting in United States.Physicians' preference values for hepatitis C health states and antiviral therapy: a surveyEffects of psycho-educational intervention on health-related quality of life (QOL) of patients with chronic liver disease referring to Shiraz University of Medical SciencesAberrant post-translational protein modifications in the pathogenesis of alcohol-induced liver injuryPrevalence of Hepatitis C Virus Genotypes Among Patients in Countries of the Eastern Mediterranean Regional Office of WHO (EMRO): A Systematic Review and Meta-AnalysisKASL clinical practice guidelines: management of hepatitis CFour-dimensional flow magnetic resonance imaging in cirrhosis.Treating hepatitis C - what's new?Treatment strategies for chronic hepatitis C prior to and following liver transplantationChronic Hepatitis C: An Overview of Evidence on Epidemiology and Management from a Brazilian Perspective.Hepatitis C genotype 4: The past, present, and futureLiver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact.Clinical Advances in Fibrosis Progression of Chronic Hepatitis B and CHepatitis C Recurrence after Orthotopic Liver Transplantation: Mechanisms and ManagementHepatitis C cirrhosis: New perspectives for diagnosis and treatmentHepatitis C virus (HCV) infection in Africa: a reviewThyroid disease in chronic hepatitis C infection treated with combination interferon-α and ribavirin: management strategies and future perspectiveIs sustained virological response a marker of treatment efficacy in patients with chronic hepatitis C viral infection with no response or relapse to previous antiviral intervention?Association between Schistosomiasis mansoni and hepatitis C: systematic reviewAging and liver diseaseHepatitis C virus: A global viewAutophagy in hepatitis C virus-host interactions: potential roles and therapeutic targets for liver-associated diseasesMetabolic factors and chronic hepatitis C: a complex interplayDifferent hepatitis C virus (HCV) RNA load profiles following seroconversion among injecting drug users without correlation with HCV genotype and serum alanine aminotransferase levels.Production and Characterization of Monoclonal Antibodies Specific for a Conserved Epitope within Hepatitis C Virus Hypervariable Region 1Chronic viral hepatitis C: management updateSelectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells.Comparison of serum hepatitis C virus RNA and core antigen concentrations and determination of whether levels are associated with liver histology or affected by specimen storage time.The natural history of hepatitis C virus (HCV) infection.
P2860
Q21245597-1839617A-1176-482E-AD71-EB2EA3086389Q21261812-F9365DCA-1282-47DA-9409-A21D7AC4C372Q22299128-3BF8DDE8-BA8A-4EA3-824A-731A53776ECDQ22305502-6D98663D-DC6F-4834-9D69-83CF3B35362AQ24186846-F6B64623-A977-46ED-A10E-A4C9CFD248B9Q24186859-14F3BFE4-3D2F-4E01-AB2E-CC26C4066510Q24240057-E0654A45-ED9F-4C5F-93A1-165E4C7B23ABQ24240879-58D89013-8DED-441A-ABC6-6744EE613603Q24243194-99F75304-4B22-450F-BCE8-63B7F78B78C1Q24243723-4F91A717-1345-401E-BC45-59583C5DD04BQ24246925-9FDE7108-9EB8-41B7-9625-293C867AFAC1Q24791398-0B04A14D-EA46-432D-8166-817753FE9861Q24802683-4B1F2622-7352-4F69-805D-FFF6F16F5531Q25255739-A70B8276-43C0-410C-B9C0-0861EDFAE2BBQ26741179-85496160-8586-4758-AF63-9CDE3B5FF573Q26747679-6E8D3539-8A6E-41E3-ACB5-C9D8C6C88946Q26752471-28685ED9-2963-4FE5-8B33-4BD3DA67DE18Q26769606-02B3FC93-7E6B-4CE3-BD9A-E3E92463871BQ26769646-82CB2474-17F7-4FF9-B277-F1B61CD705EBQ26771244-DF26BFAA-0220-41AE-90E1-B77EFA79756EQ26773585-4CF14AAF-7653-4EE7-839B-2AA707C29CEDQ26775815-19F8570E-373B-403D-9918-6109F5DB8862Q26777511-B4B9860D-1154-46E6-A05D-8DAAB851C011Q26781789-368E7872-E81C-480B-93B0-5FA4E3F2B41FQ26781984-4226E749-92E8-4D9E-B617-C883A4CEBE6EQ26799924-78E8D00A-2029-4D12-B510-ACA28E353329Q26824322-F796DCB2-0363-4BB7-B92E-4FF83FF41CD2Q26827517-2F99037B-13D6-4AE6-A6F5-41D0EBF8BEE1Q26830804-E02181C1-469A-427E-8CB3-8C1A8DB04D68Q26849292-AA4DF9CE-FCA2-4A1C-B38B-CDD080E71425Q26852595-50EA1B70-3B85-4F9C-8D7C-A51A2265D72EQ26862531-4D2B95EB-EA75-400F-9B06-C7511A568E88Q26992256-CF9F6046-AEF4-4F1E-92F3-4906D1034EADQ27011787-D1E010B6-1112-4B4D-BA09-70A471BA0CC1Q27469391-03BD3C8F-04AA-44DF-8FB3-61A718162042Q27470002-DD6D0A9B-377B-45C4-8298-CB351505C07CQ27471844-D397E947-B7E0-49BA-A2CD-B950A109FB00Q27472846-8564561E-3AEB-4148-B2FB-D89169463ABCQ27473052-2C694CB3-565B-4C5F-90F9-600B7B03ADCBQ27473116-7A01341E-F407-4BEF-A7A9-218A1ACEEACA
P2860
Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups
description
1997 nî lūn-bûn
@nan
1997 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մարտին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Natural history of liver fibro ...... , CLINIVIR, and DOSVIRC groups
@ast
Natural history of liver fibro ...... , CLINIVIR, and DOSVIRC groups
@en
type
label
Natural history of liver fibro ...... , CLINIVIR, and DOSVIRC groups
@ast
Natural history of liver fibro ...... , CLINIVIR, and DOSVIRC groups
@en
prefLabel
Natural history of liver fibro ...... , CLINIVIR, and DOSVIRC groups
@ast
Natural history of liver fibro ...... , CLINIVIR, and DOSVIRC groups
@en
P3181
P1433
P1476
Natural history of liver fibro ...... , CLINIVIR, and DOSVIRC groups
@en
P2093
P304
P3181
P356
10.1016/S0140-6736(96)07642-8
P407
P577
1997-03-22T00:00:00Z